SUGAMMADEX-TEVA sugammadex (as sodium) 200 mg/2 mL solution for injection vial أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

sugammadex-teva sugammadex (as sodium) 200 mg/2 ml solution for injection vial

teva pharma australia pty ltd - sugammadex sodium, quantity: 217.6 mg (equivalent: sugammadex, qty 200 mg) - injection, solution - excipient ingredients: water for injections; sodium hydroxide; hydrochloric acid - reversal of neuromuscular blockade induced by rocuronium or vecuronium in patients 2 years of age and older.

Sugammadex Piramal الاتحاد الأوروبي - الإنجليزية - EMA (European Medicines Agency)

sugammadex piramal

piramal critical care b.v. - sugammadex sodium - neuromuscular blockade - sugammadex - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults.

SUGAMMADEX-TEVA sugammadex (as sodium) 500 mg/5 mL solution for injection vial أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

sugammadex-teva sugammadex (as sodium) 500 mg/5 ml solution for injection vial

teva pharma australia pty ltd - sugammadex sodium, quantity: 544 mg (equivalent: sugammadex, qty 500 mg) - injection, solution - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide - reversal of neuromuscular blockade induced by rocuronium or vecuronium in patients 2 years of age and older.

Sugammadex Mylan الاتحاد الأوروبي - الإنجليزية - EMA (European Medicines Agency)

sugammadex mylan

mylan ireland limited - sugammadex sodium - neuromuscular blockade - all other therapeutic products - reversal of neuromuscular blockade induced by   rocuronium or vecuronium in adults.for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Sugammadex Fresenius Kabi الاتحاد الأوروبي - الإنجليزية - EMA (European Medicines Agency)

sugammadex fresenius kabi

fresenius kabi deutschland gmbh - sugammadex sodium - neuromuscular blockade - all other therapeutic products - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults.for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Sugammadex Adroiq الاتحاد الأوروبي - الإنجليزية - EMA (European Medicines Agency)

sugammadex adroiq

extrovis eu ltd. - sugammadex sodium - neuromuscular blockade - all other therapeutic products - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults.for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Sugammadex Amomed الاتحاد الأوروبي - الإنجليزية - EMA (European Medicines Agency)

sugammadex amomed

aop orphan pharmaceuticals gmbh - sugammadex sodium - neuromuscular blockade - all other therapeutic products - reversal of neuromuscular blockade induced by rocuronium or vecuronium.for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Sugammadex 100 mg/ml Solution for Injection أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

sugammadex 100 mg/ml solution for injection

baxter holding b.v. - sugammadex sodium - solution for injection - sugammadex

Sugammadex Rowex 100 mg/ml solution for injection أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

sugammadex rowex 100 mg/ml solution for injection

rowex ltd - sugammadex sodium - solution for injection - 100 milligram(s)/millilitre - sugammadex

Sugammadex Clonmel 100 mg/ml solution for injection أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

sugammadex clonmel 100 mg/ml solution for injection

clonmel healthcare ltd - sugammadex sodium - solution for injection - sugammadex